Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Lung Cancer (Amsterdam, Netherlands)|September 27, 2020
Robust assessment of tumor mutational burden in cytological specimens from lung cancer patientsIlaria Alborelli, Ivana Bratic Hench, Obinna Chijioke, et al.
Acta Neuropathologica|December 11, 2007
MAPT S305I mutation: implications for argyrophilic grain diseaseGabor G Kovacs, Alan Pittman, Tamas Revesz, et al.
Nature Cell Biology|June 9, 2009
Transmission and spreading of tauopathy in transgenic mouse brainFlorence Clavaguera, Tristan Bolmont, R Anthony Crowther, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2013
Brain homogenates from human tauopathies induce tau inclusions in mouse brainFlorence Clavaguera, Hiroyasu Akatsu, Graham Fraser, et al.
Current Neurovascular Research|October 28, 2015
Identification of Inflammatory, Metabolic, and Cell Survival Pathways Contributing to Cerebral Small Vessel Disease by Postmortem Gene Expression MicroarrayMarie-Françoise Ritz, Caspar Grond-Ginsbach, Manja Kloss, et al.
Plos One|June 28, 2007
Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumorsJean-Louis Boulay, André R Miserez, Christian Zweifel, et al.
Cell Reports|August 9, 2018
Neuronal Mitochondrial Dysfunction Activates the Integrated Stress Response to Induce Fibroblast Growth Factor 21Lisa Michelle Restelli, Björn Oettinghaus, Mark Halliday, et al.
The Journal of Pathology|September 1, 2019
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancerIlaria Alborelli, Katharina Leonards, Sacha I Rothschild, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 13, 2014
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophyJacopo C DiFrancesco, Francesca Novara, Orsetta Zuffardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance pStefan Kneifel, Dominik Cordier, Stephan Good, et al.
Pageof 8